Visomitin is a mitochondrial-targeted antioxidant developed as a novel therapeutic agent for treating inflammation associated with ocular surface diseases, including dry eye disease and corneal wounds.… Read more





Visomitin is a mitochondrial-targeted antioxidant developed as a novel therapeutic agent for treating inflammation associated with ocular surface diseases, including dry eye disease and corneal wounds. This category provides a comprehensive range of analytical tools necessary for rigorous pharmaceutical research and development. Laboratories utilize these high-quality Visomitin reference standards, including the active pharmaceutical ingredient and its related impurities, for impurity profiling and method validation. The collection also includes stable isotope labelled compounds, which act as vital internal standards in mass spectrometry-based assays for precise quantification in complex biological matrices. By incorporating these precise materials into analytical workflows, researchers ensure compliance with quality control protocols and support the stability and safety assessment of drug formulations throughout the lifecycle of development.